Synthesis and antimicrobial activity of novel 2-(aryl)-3-[5-(2-oxo-2 H-3-chromenyl)-1,3-oxazol-2-yl]-1,3-thiazolan-4-ones.

A series of novel 2-(aryl)-3-[5-(2-oxo-2 H-3-chromenyl)-1,3-oxazol-2-yl]-1,3-thiazolan-4-ones have been synthesized and assayed for their antibacterial activity against Gram-positive bacteria viz. Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 6538p), Micrococcus luteus (IFC 12708), and Gram-negative bacteria viz. Proteus vulgaris (ATCC 3851), Salmonella typhimurium (ATCC 14028), Escherichia coli (ATCC 25922), and also antifungal activity against Candida albicans (ATCC 10231), Aspergillus fumigatus (HIC 6094), Trichophyton rubrum (IFO 9185), and Trichophyton mentagrophytes (IFO 40996). Among the screened compounds, , , , , and exhibited potent inhibitory activity compared with the standard drug at the tested concentrations. The results reveal that, the presence of difluorophenyl in and pipernyl ring in at 2-position of thiazolidine-4-one ring show significant inhibitory activity. The other compounds also showed appreciable activity against the test bacteria and fungi and emerged as potential molecules for further development. J. Heterocyclic Chem., 2011. [ABSTRACT FROM AUTHOR]